Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes

NCT03466775 is registered in ClinicalTrials.gov with Paris Translational Research Center for Organ Transplantation as lead sponsor.

NCT NCT03466775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03466775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes
Lead sponsor
Paris Translational Research Center for Organ Transplantation
Phase
Observational
Overall status
Completed
Start date
January 1, 2008
Completion date
December 31, 2017
Enrollment
1,845 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant failure and rejection